1. Home
  2. SDRL vs VCYT Comparison

SDRL vs VCYT Comparison

Compare SDRL & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seadrill Limited

SDRL

Seadrill Limited

HOLD

Current Price

$48.90

Market Cap

3.0B

Sector

Energy

ML Signal

HOLD

Logo Veracyte Inc.

VCYT

Veracyte Inc.

HOLD

Current Price

$42.67

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SDRL
VCYT
Founded
2005
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medical Specialities
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.1B
IPO Year
2018
2013

Fundamental Metrics

Financial Performance
Metric
SDRL
VCYT
Price
$48.90
$42.67
Analyst Decision
Buy
Strong Buy
Analyst Count
4
7
Target Price
$56.00
$44.00
AVG Volume (30 Days)
523.0K
1.2M
Earning Date
05-11-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
54.61
164.52
EPS
0.36
0.66
Revenue
$1,437,000,000.00
N/A
Revenue This Year
$5.22
$13.76
Revenue Next Year
$16.68
$12.35
P/E Ratio
$138.26
$67.45
Revenue Growth
3.75
N/A
52 Week Low
$28.10
$29.46
52 Week High
$55.47
$60.91

Technical Indicators

Market Signals
Indicator
SDRL
VCYT
Relative Strength Index (RSI) 63.18 46.10
Support Level $45.74 $40.80
Resistance Level $55.47 $46.15
Average True Range (ATR) 1.55 1.73
MACD 0.20 0.62
Stochastic Oscillator 75.05 75.06

Price Performance

Historical Comparison
SDRL
VCYT

About SDRL Seadrill Limited

Seadrill Ltd is an offshore drilling contractor company. The company is engaged in providing offshore drilling services to the oil and gas industry. The primary business of the company is the ownership and operation of drillships, semi-submersible rigs, and jack-up rigs for operations in shallow to ultra-deepwater areas in both benign and harsh environments. The geographical segments of the company are the United States, Brazil, Angola, Norway, and others. The company derives maximum revenue from Brazil.

About VCYT Veracyte Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).

Share on Social Networks: